(2022-2031) Erythropoietin (EPO) Market Size, Share, Growth And Trends
Posted by ramacharitbrc on May 10th, 2022
The Erythropoietin (EPO) Global Market Report 2021-31 by The Business Research Company describes and explains the global erythropoietin (EPO) market and covers 2016 to 2021, termed the historic period, and 2022 to 2026, termed the forecast period, along with further forecasts for the period 2026-2031. The report evaluates the market across each region and for the major economies within each region.
The Erythropoietin (EPO) Global Market Report 2022 covers erythropoietin (EPO) market drivers, erythropoietin (EPO) market trends, erythropoietin (EPO) market segments, erythropoietin (EPO) market growth rate, erythropoietin (EPO) market major players, and erythropoietin (EPO) market size.
View Complete Report:
The erythropoietin (EPO) market report provides in-depth analysis of the impact of COVID-19 on the global erythropoietin industry along with revised market numbers due to the effects of the coronavirus and the expected EPO market growth numbers for 2022-2031.
The global erythropoietin market size is expected to grow from .45 billion in 2021 to .94 billion in 2022 at a compound annual growth rate (CAGR) of 11.9%. The growth in the market is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The EPO market share is expected to reach .46 billion in 2026 at a CAGR of 11.4%.
Request Report Sample Now:
Erythropoietin (EPO) Global Market Report 2022 is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies. The chapter on the impact of COVID-19 gives valuable insights on supply chain disruptions, logistical challenges, and other economic implications of the virus on the market. The chapter also covers markets which have been positively affected by the pandemic.
TBRC’s report covers the EPO market segments-
1) By Product: Epoetin-Alfa, Epoetin-Beta, Darbepoetin-Alfa, Others
2) By Application: Cancer, Hematology, Renal Diseases, Neurology, Others
3) By Drug Class: Biologics, Biosimilar
About The Business Research Company:
The Business Research Company is a market intelligence firm that excels in company, market, and consumer research. Located globally it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology. It has offices in the UK, the US and India and a network of trained researchers in 20+ countries globally.